封面
市場調查報告書
商品編碼
1786829

POC脂質檢驗的全球市場,規模,佔有率,趨勢,產業分析報告:各產品,各用途,各適應疾病,各最終用途,各地區 - 市場預測,2025年~2034年

Point of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Application, By Disease Indication, By End Use, By Region - Market Forecast, 2025-2034

出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究,即時血脂檢測市場規模預計到 2034 年將達到 13.9297 億美元。本研究報告深入分析了當前的市場動態,並分析了未來的市場成長。

即時血脂檢測是一種診斷工具,用於直接在患者護理點測量血脂水平,例如總膽固醇、高密度脂蛋白 (HDL)、低密度脂蛋白 (LDL) 和三酸甘油酯。它們只需少量血液樣本即可快速獲得結果,通常只需幾分鐘,無需中心實驗室。

各國政府和衛生組織正在推廣常規膽固醇篩檢,將其作為旨在減少心臟病的國家衛生計畫的一部分。許多公共衛生運動強調早期發現和定期血脂檢測,特別針對具有肥胖、糖尿病和心血管疾病家族史等風險因素的人。一些國家正在為地方診所和藥房的即時血脂檢測提供資金和激勵措施。這些措施有助於標準化並提高即時血脂檢測在人群中的利用率。強有力的政策支持和資金將進一步加速市場成長和可及性。

人們日益從被動醫療轉向預防性醫療,目標是及早發現疾病或完全避免疾病。血脂檢測是指在症狀出現之前識別心臟病及相關疾病風險的重要工具。即時血脂檢測設備使這一過程更快、更簡便,鼓勵人們更頻繁地進行檢測,尤其是在高風險族群中。這些檢測透過實現早期介入和生活方式的改變,有助於改善健康狀況。患者和醫療保健提供者對預防性醫療的認識不斷提高,顯著增加了對便利血脂檢測方案的需求,從而推動了即時血脂檢測市場的成長。

即時血脂檢測市場報告重點

預計到2024年,耗材市場將佔最大佔有率。這些耗材是每次檢測的必需品,需要定期更換,從而推動持續的需求。

由於肥胖率上升,高三酸甘油脂血症變得越來越普遍,預計高三酸甘油酯血症市場在預測期內將經歷顯著增長。

受心血管疾病盛行率上升、人口老化和醫療基礎設施改善的推動,北美市場在2024年佔最大佔有率。

受心血管疾病患者增加、健康意識增強以及醫療服務可及性提高的推動,預計亞太市場在預測期內將經歷顯著增長。

全球主要市場參與者包括雅培實驗室、Callegari Srl、羅氏公司、美納里尼集團、MiCoBio、Nova Biomedical 和 SD Biosensor, Inc.

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球POC脂質檢驗市場洞察

  • 市場概述
  • POC脂質檢驗市場動態
    • 促進因素和機會
      • 高齡化社會
      • 心血管疾病盛行率上升
    • 限制因素和課題
      • 高初始投資
  • PESTEL分析
  • POC脂質檢驗市場趨勢
  • 價值鏈分析

第5章 全球POC脂質檢驗市場:各產品

  • 主要調查結果
  • 簡介
  • 設備
  • 消耗品

第6章 全球POC脂質檢驗市場:各用途

  • 主要調查結果
  • 簡介
  • 高血脂症
  • 高三酸甘油脂血症
  • 丹吉爾病
  • 高脂蛋白血症
  • 家族性高膽固醇血症
  • 其他

第7章 全球POC脂質檢驗市場:各適應疾病

  • 主要調查結果
  • 簡介
  • 脂質·脂蛋白疾病
  • 動脈硬化症
  • 肝臟·腎臟疾病
  • 糖尿病
  • 其他

第8章 全球POC脂質檢驗市場:各最終用途

  • 主要調查結果
  • 簡介
  • 醫院
  • 診所
  • 研究·診斷研究所
  • 其他

第9章 全球POC脂質檢驗市場:各地區

  • 主要調查結果
  • 簡介
    • POC脂質檢驗市場分析:各地區,2020年~2034年
  • 北美
    • 北美:各產品,2020~2034年
    • 北美:各用途,2020~2034年
    • 北美:各疾病,2020~2034年
    • 北美:各最終用途,2020~2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各產品,2020~2034年
    • 歐洲:各用途,2020~2034年
    • 歐洲:各疾病,2020~2034年
    • 歐洲:各最終用途,2020~2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各產品,2020~2034年
    • 亞太地區:各用途,2020~2034年
    • 亞太地區:各疾病,2020年~2034年
    • 亞太地區:各最終用途,2020~2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各產品,2020~2034年
    • 中東·非洲:各用途,2020~2034年
    • 中東·非洲:各疾病,2020年~2034年
    • 中東·非洲:各最終用途,2020~2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各產品,2020~2034年
    • 南美:各用途,2020~2034年
    • 南美:各疾病,2020年~2034年
    • 南美:各最終用途,2020~2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Abbott Laboratories
  • Callegari Srl
  • F. Hoffmann-La Roche Ltd.
  • Menarini Group
  • MiCoBio
  • Nova Biomedical
  • SD Biosensor, Inc.
  • Sinocare Inc.
  • VivaChek Biotech(Hangzhou)Co., Ltd.
Product Code: PM6107

The point of care (POC) lipid test market size is expected to reach USD 1,392.97 million by 2034, according to a new study by Polaris Market Research. The report "Point of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Application, By Disease Indication, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

A point of care (POC) lipid test is a diagnostic tool used to measure lipid levels such as total cholesterol, HDL, LDL, and triglycerides, directly at the site of patient care. It provides rapid results from a small blood sample, often within minutes, without needing a central laboratory.

Governments and health organizations are promoting routine cholesterol screening as part of national health programs aimed at reducing heart disease. Many public health campaigns emphasize early detection and regular lipid testing, especially for people with risk factors such as obesity, diabetes, or a family history of cardiovascular conditions. Some countries further provide funding or incentives for point of care testing in community clinics and pharmacies. These efforts are helping to normalize and increase the use of POC lipid tests across populations. Strong policy support and funding further accelerate the growth and accessibility of the market.

There is a growing shift from reactive to preventive healthcare, where the goal is to catch diseases early or avoid them altogether. Lipid testing is a key tool in identifying risks for heart disease and related conditions before symptoms appear. Point of care testing devices make this process faster and easier, encouraging more frequent testing, especially in high-risk groups. These tests support better health outcomes by enabling early intervention and lifestyle changes. The demand for convenient lipid testing options is increasing significantly as awareness of preventive care rises among both patients and providers, thereby driving the POC lipid test market growth.

Point of Care Lipid Test Market Report Highlights

In 2024, the consumables segment dominated with the largest share as these items are essential for every test and need to be replaced regularly, fueling consistent demand.

The hypertriglyceridemia segment is expected to experience significant growth during the forecast period as hypertriglyceridemia is becoming increasingly common due to rising obesity rates.

The market in North America dominated with the largest share in 2024, driven by rising cardiovascular disease prevalence, an aging population, and well-established healthcare infrastructure.

The Asia Pacific market is projected to witness substantial growth during the forecast period, driven by increasing cardiovascular disease cases, growing health awareness, and expanding access to healthcare services.

A few global key market players are Abbott Laboratories; Callegari Srl; F. Hoffmann-La Roche Ltd.; Menarini Group; MiCoBio; Nova Biomedical; SD Biosensor, Inc.; Sinocare Inc.; and VivaChek Biotech (Hangzhou) Co., Ltd.

Polaris Market Research has segmented the point of care lipid test market report on the basis of product, application, disease indication, end use, and region:

By Product (Revenue - USD Million, 2020-2034)

Instruments

Consumables

By Application (Revenue - USD Million, 2020-2034)

Hyperlipidemia

Hypertriglyceridemia

Tangier Disease

Hyperlipoproteinemia

Familial Hypercholesterolemia

Others

By Disease Indication (Revenue - USD Million, 2020-2034)

Lipid and Lipoprotein Disorders

Atherosclerosis

Liver and Renal Diseases

Diabetes Mellitus

Others

By End Use (Revenue - USD Million, 2020-2034)

Hospitals

Clinics

Research and Diagnostic Laboratories

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Point of Care Lipid Test Market Insights

  • 4.1. Point of Care Lipid Test Market - Market Snapshot
  • 4.2. Point of Care Lipid Test Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Ageing Population
      • 4.2.1.2. Rising Prevalence of Cardiovascular Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Investment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Point of Care Lipid Test Market Trends
  • 4.6. Value Chain Analysis

5. Global Point of Care Lipid Test Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • 5.3. Instruments
    • 5.3.1. Global Point of Care Lipid Test Market, by Instruments, by Region, 2020-2034 (USD million)
  • 5.4. Consumables
    • 5.4.1. Global Point of Care Lipid Test Market, by Consumables, by Region, 2020-2034 (USD million)

6. Global Point of Care Lipid Test Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • 6.3. Hyperlipidemia
    • 6.3.1. Global Point of Care Lipid Test Market, by Hyperlipidemia, by Region, 2020-2034 (USD million)
  • 6.4. Hypertriglyceridemia
    • 6.4.1. Global Point of Care Lipid Test Market, by Hypertriglyceridemia, by Region, 2020-2034 (USD million)
  • 6.5. Tangier Disease
    • 6.5.1. Global Point of Care Lipid Test Market, by Tangier Disease, by Region, 2020-2034 (USD million)
  • 6.6. Hyperlipoproteinemia
    • 6.6.1. Global Point of Care Lipid Test Market, by Hyperlipoproteinemia, by Region, 2020-2034 (USD million)
  • 6.7. Familial Hypercholesterolemia
    • 6.7.1. Global Point of Care Lipid Test Market, by Familial Hypercholesterolemia, by Region, 2020-2034 (USD million)
  • 6.8. Others
    • 6.8.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020-2034 (USD million)

7. Global Point of Care Lipid Test Market, by Disease Indication

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Point of Care Lipid Test Market, by Medical Biotechnology, 2020-2034 (USD million)
  • 7.3. Lipid and Lipoprotein Disorders
    • 7.3.1. Global Point of Care Lipid Test Market, by Lipid and Lipoprotein Disorders, by Region, 2020-2034 (USD million)
  • 7.4. Atherosclerosis
    • 7.4.1. Global Point of Care Lipid Test Market, by Atherosclerosis, by Region, 2020-2034 (USD million)
  • 7.5. Liver and Renal Diseases
    • 7.5.1. Global Point of Care Lipid Test Market, by Liver and Renal Diseases, by Region, 2020-2034 (USD million)
  • 7.6. Diabetes Mellitus
    • 7.6.1. Global Point of Care Lipid Test Market, by Diabetes Mellitus, by Region, 2020-2034 (USD million)
  • 7.7. Others
    • 7.7.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020-2034 (USD million)

8. Global Point of Care Lipid Test Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • 8.3. Hospitals
    • 8.3.1. Global Point of Care Lipid Test Market, by Hospitals, by Region, 2020-2034 (USD million)
  • 8.4. Clinics
    • 8.4.1. Global Point of Care Lipid Test Market, by Clinics, by Region, 2020-2034 (USD million)
  • 8.5. Research and Diagnostic Laboratories
    • 8.5.1. Global Point of Care Lipid Test Market, by Research and Diagnostic Laboratories, by Region, 2020-2034 (USD million)
  • 8.6. Others
    • 8.6.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020-2034 (USD million)

9. Global Point of Care Lipid Test Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Point of Care Lipid Test Market Assessment, By Geography, 2020-2034 (USD million)
  • 9.3. Point of Care Lipid Test Market - North America
    • 9.3.1. North America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
    • 9.3.2. North America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
    • 9.3.3. North America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
    • 9.3.4. North America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.3.5. Point of Care Lipid Test Market - US
      • 9.3.5.1. US: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.3.5.2. US: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.3.5.3. US: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.3.5.4. US: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.3.6. Point of Care Lipid Test Market - Canada
      • 9.3.6.1. Canada: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.3.6.2. Canada: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.3.6.3. Canada: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.3.6.4. Canada: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • 9.4. Point of Care Lipid Test Market - Europe
    • 9.4.1. Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
    • 9.4.2. Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
    • 9.4.3. Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
    • 9.4.4. Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.5. Point of Care Lipid Test Market - UK
      • 9.4.5.1. UK: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.5.2. UK: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.5.3. UK: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.5.4. UK: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.6. Point of Care Lipid Test Market - France
      • 9.4.6.1. France: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.6.2. France: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.6.3. France: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.6.4. France: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.7. Point of Care Lipid Test Market - Germany
      • 9.4.7.1. Germany: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.7.2. Germany: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.7.3. Germany: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.7.4. Germany: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.8. Point of Care Lipid Test Market - Italy
      • 9.4.8.1. Italy: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.8.2. Italy: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.8.3. Italy: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.8.4. Italy: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.9. Point of Care Lipid Test Market - Spain
      • 9.4.9.1. Spain: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.9.2. Spain: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.9.3. Spain: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.9.4. Spain: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.10. Point of Care Lipid Test Market - Netherlands
      • 9.4.10.1. Netherlands: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.10.2. Netherlands: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.10.3. Netherlands: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.10.4. Netherlands: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.11. Point of Care Lipid Test Market - Russia
      • 9.4.11.1. Russia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.11.2. Russia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.11.3. Russia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.11.4. Russia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.12. Point of Care Lipid Test Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.12.2. Rest of Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.12.3. Rest of Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.12.4. Rest of Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • 9.5. Point of Care Lipid Test Market - Asia Pacific
    • 9.5.1. Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
    • 9.5.2. Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
    • 9.5.3. Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
    • 9.5.4. Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.5. Point of Care Lipid Test Market - China
      • 9.5.5.1. China: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.5.2. China: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.5.3. China: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.5.4. China: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.6. Point of Care Lipid Test Market - India
      • 9.5.6.1. India: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.6.2. India: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.6.3. India: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.6.4. India: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.7. Point of Care Lipid Test Market - Malaysia
      • 9.5.7.1. Malaysia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.7.2. Malaysia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.7.3. Malaysia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.7.4. Malaysia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.8. Point of Care Lipid Test Market - Japan
      • 9.5.8.1. Japan: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.8.2. Japan: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.8.3. Japan: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.8.4. Japan: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.9. Point of Care Lipid Test Market - Indonesia
      • 9.5.9.1. Indonesia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.9.2. Indonesia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.9.3. Indonesia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.9.4. Indonesia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.10. Point of Care Lipid Test Market - South Korea
      • 9.5.10.1. South Korea: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.10.2. South Korea: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.10.3. South Korea: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.10.4. South Korea: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.11. Point of Care Lipid Test Market - Australia
      • 9.5.11.1. Australia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.11.2. Australia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.11.3. Australia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.11.4. Australia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.12. Point of Care Lipid Test Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.12.2. Rest of Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.12.3. Rest of Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.12.4. Rest of Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • 9.6. Point of Care Lipid Test Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
    • 9.6.2. Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
    • 9.6.3. Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
    • 9.6.4. Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.6.5. Point of Care Lipid Test Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.6.5.2. Saudi Arabia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.6.5.3. Saudi Arabia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.6.5.4. Saudi Arabia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.6.6. Point of Care Lipid Test Market - UAE
      • 9.6.6.1. UAE: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.6.6.2. UAE: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.6.6.3. UAE: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.6.6.4. UAE: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.6.7. Point of Care Lipid Test Market - Israel
      • 9.6.7.1. Israel: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.6.7.2. Israel: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.6.7.3. Israel: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.6.7.4. Israel: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.6.8. Point of Care Lipid Test Market - South Africa
      • 9.6.8.1. South Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.6.8.2. South Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.6.8.3. South Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.6.8.4. South Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.6.9. Point of Care Lipid Test Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.6.9.2. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.6.9.3. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.6.9.4. Rest of Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • 9.7. Point of Care Lipid Test Market - Latin America
    • 9.7.1. Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
    • 9.7.2. Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
    • 9.7.3. Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
    • 9.7.4. Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.7.5. Point of Care Lipid Test Market - Mexico
      • 9.7.5.1. Mexico: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.7.5.2. Mexico: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.7.5.3. Mexico: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.7.5.4. Mexico: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.7.6. Point of Care Lipid Test Market - Brazil
      • 9.7.6.1. Brazil: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.7.6.2. Brazil: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.7.6.3. Brazil: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.7.6.4. Brazil: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.7.7. Point of Care Lipid Test Market - Argentina
      • 9.7.7.1. Argentina: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.7.7.2. Argentina: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.7.7.3. Argentina: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.7.7.4. Argentina: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.7.8. Point of Care Lipid Test Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.7.8.2. Rest of Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.7.8.3. Rest of Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.7.8.4. Rest of Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Callegari Srl
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. F. Hoffmann-La Roche Ltd.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Menarini Group
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. MiCoBio
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Nova Biomedical
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. SD Biosensor, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Sinocare Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. VivaChek Biotech (Hangzhou) Co., Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development

List of Tables:

  • Table 1 Global Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 2 Global Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 3 Global Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 4 Global Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 5 North America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 6 North America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 7 North America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 8 North America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 9 US: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 10 US: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 11 US: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 12 US: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 13 Canada: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 14 Canada: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 15 Canada: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 16 Canada: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 17 Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 18 Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 19 Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 20 Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 21 UK: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 22 UK: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 23 UK: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 24 UK: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 25 France: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 26 France: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 27 France: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 28 France: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 29 Germany: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 30 Germany: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 31 Germany: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 32 Germany: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 33 Italy: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 34 Italy: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 35 Italy: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 36 Italy: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 37 Spain: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 38 Spain: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 39 Spain: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 40 Spain: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 41 Netherlands: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 42 Netherlands: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 43 Netherlands: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 44 Netherlands: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 45 Russia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 46 Russia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 47 Russia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 48 Russia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 49 Rest of Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 50 Rest of Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 51 Rest of Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 52 Rest of Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 53 Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 54 Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 55 Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 56 Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 57 China: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 58 China: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 59 China: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 60 China: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 61 India: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 62 India: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 63 India: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 64 India: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 65 Malaysia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 66 Malaysia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 67 Malaysia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 68 Malaysia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 69 Japan: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 70 Japan: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 71 Japan: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 72 Japan: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 73 Indonesia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 74 Indonesia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 75 Indonesia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 76 Indonesia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 77 South Korea: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 78 South Korea: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 79 South Korea: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 80 South Korea: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 81 Australia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 82 Australia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 83 Australia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 84 Australia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 85 Rest of Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 86 Rest of Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 87 Rest of Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 88 Rest of Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 89 Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 90 Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 91 Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 92 Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 93 Saudi Arabia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 94 Saudi Arabia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 95 Saudi Arabia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 96 Saudi Arabia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 97 UAE: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 98 UAE: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 99 UAE: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 100 UAE: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 101 Israel: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 102 Israel: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 103 Israel: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 104 Israel: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 105 South Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 106 South Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 107 South Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 108 South Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 109 Rest of Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 110 Rest of Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 111 Rest of Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 112 Rest of Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 113 Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 114 Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 115 Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 116 Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 117 Mexico: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 118 Mexico: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 119 Mexico: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 120 Mexico: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 121 Brazil: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 122 Brazil: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 123 Brazil: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 124 Brazil: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 125 Argentina: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 126 Argentina: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 127 Argentina: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 128 Argentina: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 129 Rest of Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 130 Rest of Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 131 Rest of Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 132 Rest of Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)

List of Figures:

  • Figure 1. Global Point of Care Lipid Test Market, 2020-2034 (USD million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Point of Care Lipid Test Market, by Product, 2024 & 2034 (USD million)
  • Figure 8. Market by Application
  • Figure 9. Global Point of Care Lipid Test Market, by Application, 2024 & 2034 (USD million)
  • Figure 10. Market by Disease Indication
  • Figure 11. Global Point of Care Lipid Test Market, by Disease Indication, 2024 & 2034 (USD million)
  • Figure 12. Market by End Use
  • Figure 13. Global Point of Care Lipid Test Market, by End Use, 2024 & 2034 (USD million)
  • Figure 14. Global Point of Care Lipid Test Market Assessment, By Geography, 2020-2034 (USD million)
  • Figure 15. Strategic Analysis - Global Point of Care Lipid Test Market